Capital Group Private Client Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Capital Group Private Client Services's EW Position: Q1 2026 in Review
Capital Group Private Client Services sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 5,068 shares — an estimated $432K sold.
Capital Group Private Client Services first reported a position in EW in Q3 2021 and held it in 18 quarters. The position peaked at $67.5M in Q2 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Capital Group Private Client Services reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
- Capital Group Private Client Services sold 5,068 Edwards Lifesciences shares in Q1 2026, an estimated $432K.
- Capital Group Private Client Services first reported a position in Edwards Lifesciences in Q3 2021 and held it in 18 quarters.
- Capital Group Private Client Services's Edwards Lifesciences position peaked at $67.5M in Q2 2023.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Capital Group Private Client Services's 13F filing for Q1 2026, filed 13 May 2026.